Family Medicine Doctors in Anderson, IN Accepting Medicare

46 Family Medicine doctors found. Showing 41 - 46

Aisha Hashmat, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Medical Arts Boulevard, Suite 100, Anderson, IN 46011 Phone: 765-298-5700    Fax: 765-298-4913

Charles Purdy, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 141 W 22nd St, Suite 311, Anderson, IN 46016 Phone: 765-641-7100    Fax: 765-641-7115

Warren Gregory Lawless, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 2610 Enterprise Dr, Anderson, IN 46013 Phone: 800-622-6575

Blanca R David, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1601 Medical Arts Blvd, Suite 100, Anderson, IN 46011 Phone: 765-298-5700    Fax: 765-298-4913

Alton B Parker Iii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2015 Jackson St, Anderson, IN 46016 Phone: 765-649-2511

Sherwin G Ibarra, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1030 S Scatterfield Rd, Anderson, IN 46012 Phone: 765-644-5025    Fax: 765-643-4534

News Archive

Youth prefer rapid point-of-care HIV tests than traditional blood tests

Youth prefer, accept and receive HIV results more often when offered rapid finger prick or saliva swab tests rather than traditional blood tests according to a study by researchers at St. Michael's Hospital.

Study: Elevated BMI may affect survival in pancreatic cancer patients

New results from a prospective study published in the Journal of Clinical Oncology show that patients with a body mass index (BMI) in the obese range live on average two to three months less after a pancreatic cancer diagnosis, compared with healthy weight patients, even after adjusting for factors that are known to predict survival for patients with this disease, such as age and disease stage.

Medivir initiates MIV-711 phase I trial in bone disorders

Medivir AB, a research-based pharmaceutical company focused on infectious diseases, announced today that a phase I clinical trial has been initiated with its investigational drug, MIV-711, a cathepsin K inhibitor for the treatment of bone disorders characterized by excessive bone resorption such as osteoporosis, osteoarthritis and bone metastases.

Study shows how neuroactive steroids inhibit activity of pro-inflammatory proteins

For the first time, scientists discovered how neuroactive steroids naturally found in the brain and bloodstream inhibit the activity of a specific kind of protein called Toll-like receptors, which have been known to play a role in inflammation in many organs, including the brain.

OptiNose's bi-directional nasal device delivering fluticasone effective in reducing nasal polyps in CRS patients

OptiNose Inc. announced today that a subgroup analysis of positive Phase II trial results has been published in the July/August issue of the American Journal of Rhinology & Allergy.

Read more Medical News

› Verified 7 days ago

• 1
• 2
• 3(current)